ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
Home
Press release
Dec 15, 2021 10:15 JST
Source: NEC Corporation
BostonGene and NEC Announce Global Partnership
TOKYO, JAPAN and WALTHAM, Mass., Dec 15, 2021 - (JCN Newswire) - BostonGene Corporation and NEC Corporation (TSE: 6701) today announced a strategic global partnership agreement that will enable the companies to offer new windowBostonGene Tumor Portrait Tests in key international markets, including Japan as the first market outside of the U.S.
BostonGene's innovative computational platform performs AI-based molecular and immune profiling to discover correlations between tumor genomics, a patient's immune system and the effectiveness of all available approved and experimental treatments. BostonGene Tumor Portrait Tests, based on integrated genomic and transcriptomic analysis, propel precision medicine into daily clinical practice and support physicians in actualizing personalized therapy for cancer patients.
Moreover, in NEC's ongoing personalized neoantigen clinical trial that utilizes its AI-driven neoantigen prediction technology, NEC and BostonGene are collaborating to provide molecular characterization of patient tumors. Going forward, the two companies will jointly develop the market for BostonGene Tumor Portrait Tests globally. In Japan, the companies aim to utilize NEC's healthcare and life science network in order to provide Tumor Portrait Tests to hospitals throughout the country.
In 2020, 378,385 people died of cancer in Japan, according to a Ministry of Health, Labor, and Welfare report. This accounts for 27.6% of all deaths that year and equates to one in four people dying of cancer. Leveraging NEC's longstanding relationships with cancer centers, pharma and biotech companies, the organizations will work closely together to demonstrate the critical role of next generation multi-platform analytics combined with cutting-edge software to improve the diagnosis and treatment for cancer patients. Earlier this year, NEC announced an initiative to create healthcare and life science business that utilizes AI and other digital technologies as part of the "creation of future growth businesses" set forth in the 2025 Mid-term Management Plan.
"NEC has been committed to contributing to healthcare for more than half a century, which includes state-of-the-art hospital information systems in Japan. Cancer is now the country's most common cause of death, and NEC has been working with the National Cancer Center Japan since 2016. Today, NEC remains as dedicated as ever to applying our rich experience in AI and analytics for improving patients' outcomes," said Takayuki Morita, President and CEO at NEC Corporation. "BostonGene's offering of deep molecular and immune profiling, coupled with its computational power and analytics, have already improved the quality of care for cancer patients in both academic and community settings in the United States. Supporting BostonGene's international expansion enables us to continue to rapidly drive innovation that improves the standard of care in Japan and abroad."
"NEC has a long history of offering industry leading products and solutions in the field of healthcare both in Japan and globally," said Andrew Feinberg, President and CEO at BostonGene. "Partnering with NEC will allow BostonGene to expedite our international expansion which aims to improve the standard of care for cancer patients around the world."
This agreement expands upon existing collaborations between BostonGene and NEC.
About BostonGene Corporation
BostonGene's mission is to power healthcare's transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. BostonGene Tumor Portrait Tests reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene Tumor Portrait Tests generate a personalized roadmap for therapeutic decision-making for each cancer patient. For more information, visit BostonGene at
http://www.BostonGene.com
.
About NEC Corporation
NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of "Orchestrating a brighter world." NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at
https://www.nec.com
.
Sectors: MedTech
Copyright ©2022 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Eisai and Lifenet Enter Into Capital and Business Alliance Agreement Aimed at Building Ecosystem to Reduce Burden of Medical and Nursing Care
Aug 09, 2022 18:09 JST
Establishment of Maritime and Ocean Digital Engineering Cooperation Program at the University of Tokyo
Aug 08, 2022 14:46 JST
Waste-to-Energy Company in Singapore Made a Wholly-Owned Subsidiary
Aug 08, 2022 14:08 JST
Rovanpera extends WRC lead with rapid home run for TOYOTA GAZOO Racing
Aug 08, 2022 11:31 JST
Team HRC Wins 43rd Suzuka 8 Hours Endurance Race
Aug 08, 2022 11:18 JST
MHI to Issue its First Transition Bond
Aug 05, 2022 17:17 JST
Mitsubishi Heavy Industries Achieves 22% YoY Increase in Order Intake and 52% YoY Increase in Net Profit in a Challenging First Quarter
Aug 05, 2022 16:40 JST
Honda Signs Agreement to Transfer Shares of Honda Lock Mfg. to MinebeaMitsumi
Aug 05, 2022 15:24 JST
MHI Group Signs Sponsorship Agreement with Thailand's Muangthong United Football Club
Aug 04, 2022 16:44 JST
Hitachi Energy Supports Huge Step in Germany's Energy Transition
Aug 04, 2022 10:02 JST
Eisai Presents New Findings on Lecanemab's Investigational Subcutaneous Formulation and Modeling Simulation of ApoE4 Genotype on Aria-E Incidence at AAIC 2022
Aug 04, 2022 09:25 JST
Eisai and Merck & Co., Inc., Rahway, NJ, USA Provide Update on Phase 3 LEAP-002 Trial
Aug 04, 2022 09:05 JST
Honda to Extend Power Unit Technical Support Agreement with Red Bull Power Trains to End of 2025
Aug 03, 2022 09:35 JST
NEC Visionary Week 2022 to provide insights on the future of society and business
Aug 01, 2022 13:13 JST
DENSO Announces Q1 2022 Results, Details Efforts Advancing its Pursuit of Sustainability and Safety
Jul 29, 2022 18:32 JST
Mitsubishi Power Receives Order from HK Electric for Re-provision of Gas Turbine Equipment at the Lamma Power Station
Jul 29, 2022 18:25 JST
Mazda Included in MSCI Japan ESG Select Leaders Index
Jul 29, 2022 18:17 JST
TOYOTA GAZOO Racing Ready to Defend Unbeaten Home Record
Jul 29, 2022 17:27 JST
Mazda Production and Sales Results for June 2022 and for January through June 2022
Jul 29, 2022 11:16 JST
Fujitsu and Hokuhoku Financial Group develop algorithm for efficient flood risk calculation for Task Force on Climate-related Financial Disclosures (TCFD) reporting
Jul 28, 2022 15:49 JST
More Latest Release >>
Related Release
NEC Visionary Week 2022 to provide insights on the future of society and business
8/1/2022 1:13:00 PM JST
NEC to Build New Trans-Pacific Cable
7/21/2022 11:50:00 AM JST
NEC Corporation strengthens its partnership with Project Management Institute (PMI) in Asia Pacific to drive business agility
7/12/2022 11:25:00 AM JST
NEC Expands Global Solutions Delivery Capacity with Acquisition of Aspire Technology, a Network Solutions and System Integration Company
7/1/2022 12:47:00 PM JST
Milestone of THz Communication
6/29/2022 4:48:00 PM JST
Infinera and NEC to Modernize Neutral Networks' Mexico to United States Fiber Optic Network with Industry-leading ICE6 800G Solution
6/29/2022 3:35:00 PM JST
Hokkaido University and NEC conclude an agreement for developing spatial sensing to combat the spread of illness
6/28/2022 3:53:00 PM JST
NEC Australia to Participate in the Open RAN Pilot Workgroup to Transform Regional Mobile Coverage
6/17/2022 9:38:00 AM JST
Kagome and NEC establish a joint venture in Portugal to provide farming support for processed tomatoes using AI
6/15/2022 1:37:00 PM JST
Introducing a Transceiver that Can Tap into the Higher Frequency Bands of 5G Networks
6/15/2022 1:10:00 PM JST
More Press release >>